WallStreetZenWallStreetZen

NASDAQ: VIR
Vir Biotechnology Inc Stock Ownership - Who owns Vir Biotechnology?

Insider buying vs selling

Have Vir Biotechnology Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
George A. ScangosDirector2024-02-2617,722$11.65
$206.51kSell
Ann M. HanlyEVP Chief Technology Officer2024-02-2212,296$10.05
$123.53kSell
George A. ScangosDirector2024-02-2210,028$10.05
$100.74kSell
Phillip PangEVP Chief Medical Officer2024-02-2214,568$10.05
$146.35kSell
George A. ScangosDirector2024-02-2016,872$10.22
$172.38kSell
George A. ScangosDirector2024-02-1610,878$10.24
$111.39kSell
Phillip PangEVP Chief Medical Officer2024-02-163,321$10.24
$34.01kSell
Phillip PangEVP Chief Medical Officer2024-01-0218,833$0.86
$16.10kBuy
Phillip PangEVP Chief Medical Officer2024-01-0213,576$1.58
$21.38kBuy
Phillip PangEVP Chief Medical Officer2024-01-0247,591$1.53
$72.81kBuy

1 of 6

VIR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VIR insiders and whales buy or sell their stock.

VIR Shareholders

What type of owners hold Vir Biotechnology Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc12.49%16,864,579$168.14MInstitution
Svf Endurance Cayman Ltd12.36%16,684,041$166.34MInsider
Sb Investment Advisers Uk Ltd12.36%16,684,041$166.34MInstitution
Alaska Permanent Fund Corp12.34%16,666,668$166.17MInsider
Vanguard Group Inc9.11%12,297,139$122.60MInstitution
State Street Corp5.12%6,912,082$68.91MInstitution
Temasek Holdings Private Ltd4.07%5,499,999$54.83MInsider
Baillie Gifford Co2.94%3,965,549$39.54MInstitution
Dhabi Investment Authority Abu2.72%3,666,666$36.56MInsider
Citadel Advisors LLC2.25%3,037,948$30.29MInstitution

1 of 3

VIR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VIR62.22%37.78%Net SellingNet Selling
XNCR66.77%33.23%Net BuyingNet Buying
PRTA53.06%46.94%Net BuyingNet Buying
AKRO66.82%33.18%Net BuyingNet Buying
DAWN54.70%45.30%Net BuyingNet Selling

Vir Biotechnology Stock Ownership FAQ

Who owns Vir Biotechnology?

Vir Biotechnology (NASDAQ: VIR) is owned by 65.27% institutional shareholders, 39.63% Vir Biotechnology insiders, and 0.00% retail investors. Svf Endurance Cayman Ltd is the largest individual Vir Biotechnology shareholder, owning 16.68M shares representing 12.36% of the company. Svf Endurance Cayman Ltd's Vir Biotechnology shares are currently valued at $168.51M.

If you're new to stock investing, here's how to buy Vir Biotechnology stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.